Our partner required us to reach individuals across various Indian cities who were using throat lozenges prescribed by a doctor, excluding over-the-counter or self-medicated use. This throat lozenges usage case study included brand-specific quota research to ensure detailed segmentation. The project was successfully executed within just 2 days, delivering over 400 qualified completes through rapid healthcare data collection. The pharmaceutical market insights gathered from India offered valuable direction for understanding prescription-based consumer behavior and brand traction, helping refine product positioning strategies in the country's healthcare sector.

Business Challenge

A major healthcare client approached Xcel Global Panel to conduct a rapid healthcare study targeting 18-45-year-olds across Indian cities who were prescribed throat lozenges by a doctor, excluding self-medicated users.
The niche criteria, combined with brand quota management, city-wise segmentation, and a strict two-day deadline, made this more complex than typical healthcare research. The objective was to uncover prescription-driven usage patterns, brand preferences, and prescription compliance insights to guide marketing and physician-led treatment outreach in India’s urban pharma market.

Our Approach

To meet the client’s stringent requirements and tight timeline, we activated a combination of advanced targeting and panel-based recruitment intelligence:

• Smart Panel Activation: Leveraged Xcel Global Panel’s pre-profiled healthcare community to zero in on respondents who were medically prescribed throat lozenges. This pre-qualification drastically reduced screening time and enhanced data integrity, enabling validated respondent samples for more reliable medical usage insights.

• City-Wise Quota Management: Designed a stratified sampling framework to ensure representation across multiple Indian cities. Brand-level screening questions were integrated to meet the specific quotas and support city-level patient mapping for refined urban consumer profiling.

• Rapid Field Deployment: The study was launched and fully completed within just 48 hours using automated respondent validation checks, ensuring quality while scaling speed. This allowed for real-time data delivery and rapid data turnaround, essential for responsive pharma market evaluation.

Results

Within two days, the study delivered over 400 fully validated completes, all matching the client's strict inclusion criteria.
The data provided actionable insights into:

• Doctor-recommended product selection patterns

• Urban patient treatment behavior patterns and prescription loyalty

• Brand performance insights and influence across city tiers

These findings empowered the client to refine its patient targeting and physician engagement plans, focusing on regions with higher therapeutic demand signals, brand traction, and unmet awareness. The results contributed to a sharper market access strategy grounded in evidence-based marketing and real-world evidence.

Encouraged by the precision, speed, and strategic value of the study, the client has since expanded its partnership with Xcel Global Panel for broader pharma usage analytics and tracking initiatives across other therapeutic categories.

Want to reach niche healthcare audiences with speed and precision?

Partner with Xcel Global Panel for agile, high-quality data collection that drives actionable insights - even under tight timelines.